BIRC5 and cancer: The HHT mode of action in this cancer has not been precisely demonstrated although HHT decreased the cellular levels of MYC, MCL-1, SURVIVIN and also interfered with JAK1 and STAT3 phosphorylation, to decrease the levels of IL6, a growth factor for NSCLC [98].